CTNNAL1 Inhibitors
CTNNAL1 inhibitors belong to a specific class of chemical compounds designed to modulate the activity of the CTNNAL1 gene, also known as p120 catenin-like 1. CTNNAL1 is a member of the p120 catenin family, a group of proteins that play crucial roles in cell adhesion and signal transduction. These inhibitors are designed to selectively target and interfere with the function of CTNNAL1, thereby influencing cellular processes regulated by this gene. The CTNNAL1 gene encodes a protein that participates in the regulation of cell adhesion and migration, processes fundamental to various physiological and pathological conditions, including embryonic development and cancer progression.
CTNNAL1 inhibitors involves a meticulous understanding of the molecular structure and function of CTNNAL1. These inhibitors can act through various mechanisms, such as binding to specific regions of the CTNNAL1 protein to disrupt its interactions with other cellular components or by modulating its expression levels. By selectively inhibiting CTNNAL1, these compounds aim to alter cellular behaviors related to adhesion and migration, potentially influencing cellular processes in which CTNNAL1 is involved. The design and optimization of CTNNAL1 inhibitors require a comprehensive understanding of the structural biology and biochemistry of CTNNAL1, enabling the development of targeted compounds with high specificity and efficacy.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, potentially altering CTNNAL1 associated signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Acts on PI3K/Akt pathway, which might affect CTNNAL1 activity indirectly. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which is upstream of pathways CTNNAL1 might interact with. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Targets p38 MAPK, potentially modifying CTNNAL1 related signaling cascades. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, could alter cell processes involving CTNNAL1. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $35.00 $115.00 $515.00 | 26 | |
Targets Wnt/β-catenin pathway, potentially affecting CTNNAL1's functional context. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $94.00 $286.00 | 27 | |
Inhibitor of Wnt production, could change CTNNAL1's cellular role. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
Notch pathway inhibitor, might indirectly modify CTNNAL1's activity. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
Hedgehog signaling inhibitor, potentially affecting CTNNAL1's pathway interaction. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
ROCK inhibitor, could influence cellular processes related to CTNNAL1. | ||||||